Qualigen Therapeutics, Inc. - stock earnings
QLGN Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q3 | -3.7 million USD | ? USD |
2023Q2 | -3.5 million USD | 1.6 million USD |
2023Q1 | -8.5 million USD | 1.4 million USD |
2022Q4 | -6.4 million USD | 1.4 million USD |
2022Q3 | -3.8 million USD | 1.4 million USD |
2022Q2 | -4.1 million USD | 1.4 million USD |
2022Q1 | -4.3 million USD | 722029 USD |
2021Q4 | -6.1 million USD | 1.5 million USD |
2021Q3 | -2.9 million USD | 1.2 million USD |
2021Q2 | -5.3 million USD | 1.1 million USD |
2021Q1 | -3.7 million USD | 1.9 million USD |
2020Q4 | 8.8 million USD | 1.1 million USD |
2020Q3 | -8.1 million USD | 837714 USD |
2020Q2 | -18.6 million USD | 904067 USD |
2020Q1 | -1.7 million USD | ? USD |
2019Q4 | -10.1 trillion USD | -2.7 million USD |
2019Q3 | -356225 USD | 1.2 million USD |
2019Q2 | -594565 USD | 1.5 million USD |
2019Q1 | -6.6 million USD | ? USD |
2018Q3 | -4.6 million USD | ? USD |
2018Q2 | -3.6 million USD | ? USD |
2018Q1 | -2.0 million USD | ? USD |
2017Q4 | -2.2 million USD | ? USD |
2017Q3 | -2.0 million USD | ? USD |
2017Q2 | -2.0 million USD | ? USD |
2017Q1 | -1.7 million USD | ? USD |
2016Q4 | -7.6 million USD | ? USD |
2016Q3 | -3.5 million USD | ? USD |
2016Q2 | -4.1 million USD | ? USD |
2016Q1 | -3.1 million USD | ? USD |
2015Q3 | -3.1 million USD | ? USD |
2015Q2 | -2.1 million USD | ? USD |
QLGN Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | -17.3 million USD | 5.0 million USD |
2022 | -21.0 million USD | 5.0 million USD |
2021 | -17.9 million USD | 5.7 million USD |
2020 | -20.4 million USD | 4.3 million USD |
2019 | -10.1 trillion USD | 5.6 million USD |
2018 | -16.9 million USD | 5.8 million USD |
2017 | -7.9 million USD | ? USD |
2016 | -18.4 million USD | ? USD |
2015 | -9.2 million USD | ? USD |
QLGN
Price: $0.30
52 week price:
Earnings Per Share: -4.07 USD
P/E Ratio: -0.13
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 69100
Market Capitalization: 1.9 million